Control of phospholipase A2 activities for the treatment of inflammatory conditions |
| |
Authors: | Yedgar Saul Cohen Yuval Shoseyov David |
| |
Institution: | Department of Biochemistry, Hebrew University-Hadassah Medical School, Jerusalem 91120, Israel. yedgar@md.huji.ac.il |
| |
Abstract: | Phospholipase-A2 (PLA2) enzymes hydrolyze cell membrane phospholipids to produce arachidonic acid (AA) and lyso-phospholipids (LysoPL), playing a key role in the production of inflammatory lipid mediators, mainly eicosanoids. They are therefore considered pro-inflammatory enzymes and their inhibition has long been recognized as a desirable therapeutic target. However, attempts to develop suitable PLA2 inhibitors for the treatment of inflammatory diseases have yet to succeed. This is due to their functional and structural diversity, and their homeostatic and even anti-inflammatory roles in certain circumstances. In the present review we outline the diversity and functions of PLA2 isoforms, and their interplay in the induction and inhibition of inflammatory processes, with emphasis on discussing approaches for therapeutic manipulation of PLA2 activities. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|